We are live on ! Find out more
PHVS icon

Pharvaris

60 hedge funds and large institutions have $793M invested in Pharvaris in 2025 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 19 increasing their positions, 16 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

800% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 1

19% more repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 16

15% more funds holding

Funds holding: 5260 (+8)

12% more capital invested

Capital invested by funds: $706M → $793M (+$87.2M)

0% more funds holding in top 10

Funds holding in top 10: 66 (0)

0.55% less ownership

Funds ownership: 83.21%82.66% (-0.55%)

Holders
60
Holders Change
+8
Holders Change %
+15.38%
% of All Funds
0.79%
Holding in Top 10
6
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.08%
New
9
Increased
19
Reduced
16
Closed
1
Calls
Puts
Net Calls
Net Calls Change

PHVS Hedge Fund Activity: Q2 2025 in Review

60 of the 7,598 institutional investors tracked by Wall St. Rank reported a position in Pharvaris (PHVS) for Q2 2025, worth a combined $793M — up 12% from $706M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new PHVS positions and 1 closed out — a net gain of 8 holders — while 19 added to existing stakes and 16 trimmed.

The largest buyer was Paradigm Biocapital Advisors, opening a new position worth an estimated $17.1M. The largest seller was VR Adviser, cutting an estimated $17.2M.

  • 60 institutional investors held Pharvaris (PHVS) as of Q2 2025, up from 52 in Q1 2025.
  • Funds reported $793M of Pharvaris stock for Q2 2025, up 12% quarter-over-quarter.
  • 9 funds opened new Pharvaris positions in Q2 2025 and 1 closed out, a net change of +8 holders.
  • The largest Pharvaris buyer in Q2 2025 was Paradigm Biocapital Advisors, an estimated $17.1M added.
  • The largest Pharvaris seller in Q2 2025 was VR Adviser, an estimated $17.2M sold.

Based on aggregated 13F filings for Q2 2025.